½ÃÀ庸°í¼­
»óǰÄÚµå
1596673

Á¤ÀÚÀºÇà ½ÃÀå : ±âÁõÀÚ À¯Çü, ¼­ºñ½º À¯Çü, ¿ëµµ ¹× ÃÖÁ¾ ¿ëµµº° - ¼¼°è ¿¹Ãø(2025-2030³â)

Sperm Banks Market by Donor Type (Anonymous Donor, Known Donor), Service Type (Genetic Consultation, Semen Analysis, Sperm Storage), Application, End Use - Global Forecast 2025-2030

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: 360iResearch | ÆäÀÌÁö Á¤º¸: ¿µ¹® 180 Pages | ¹è¼Û¾È³» : 1-2ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡á º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼ÛÀÏÁ¤Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Á¤ÀÚÀºÇà ½ÃÀåÀº 2023³â¿¡ 47¾ï 2,000¸¸ ´Þ·¯·Î Æò°¡µÇ¾ú½À´Ï´Ù. 2024³â¿¡´Â 49¾ï 3,000¸¸ ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, CAGR 4.38%·Î ¼ºÀåÇÏ¿© 2030³â¿¡´Â 63¾ï 8,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ Àü¸ÁÀÔ´Ï´Ù.

Á¤ÀÚÀºÇà ½ÃÀåÀº ±¤¹üÀ§ÇÑ ºÒÀÓ Ä¡·á ¼­ºñ½º »ê¾÷ Áß Àΰø¼öÁ¤ ¹× ±âŸ ºÒÀÓ Ä¡·á¸¦ À§ÇØ Á¤ÀÚ¸¦ ¼öÁý, º¸°ü ¹× Á¦°øÇÏ´Â µ¥ ÁßÁ¡À» µÐ Àü¹® ºÐ¾ßÀÔ´Ï´Ù. ºÒÀÓÀ¸·Î °í¹ÎÇÏ´Â ºÎºÎ, µ¶½Å ¿©¼º, ÀÓ½ÅÀ» ¿øÇÏ´Â µ¿¼º Ä¿Çà µî ´Ù¾çÇÑ °í°´À» ´ë»óÀ¸·Î ÇÕ´Ï´Ù. Á¤ÀÚÀºÇàÀÇ Çʿ伺Àº ¶óÀÌÇÁ½ºÅ¸ÀÏÀÇ º¯È­, Áúº´, Ãâ»ê Áö¿¬, µ¶½Å ¹× LGBTQ ºÎ¸ð °¡Á·ÀÇ ¼ö¿ë Áõ°¡ µîÀ¸·Î ÀÎÇÑ ºÒÀÓ·ü Áõ°¡·Î ÀÎÇØ ¹ß»ýÇÕ´Ï´Ù. ü¿Ü¼öÁ¤(IVF)°ú °°Àº º¸Á¶»ý½Ä¼ú(ART)¿¡µµ Àû¿ëµÇ¸ç, ºÒÀÓ Ä¡·á¸¦ Áö¿øÇÏ´Â ¼±ÁøÀûÀÎ ÀÇ·á ½Ã½ºÅÛ°ú ¼±ÁøÀûÀÎ ¹ý±Ô¸¦ °¡Áø Áö¿ª¿¡¼­ Å« ¼ö¿ä°¡ ¿¹»óµË´Ï´Ù. ÃÖÁ¾ »ç¿ëÀÚ ºÎ¹®¿¡´Â ÁÖ·Î ºÒÀÓ Å¬¸®´Ð, º´¿ø, ¿¬±¸±â°üÀÌ Æ÷ÇԵ˴ϴÙ. ½ÃÀå ¼ºÀåÀº ³Ãµ¿ º¸Á¸, À¯ÀüÀÚ °Ë»ç, ±âÁõÀÚ ¼±º°À» À§ÇÑ ½ºÅ©¸®´×ÀÇ ±â¼ú ¹ßÀü¿¡ ¿µÇâÀ» ¹Þ¾Æ Àӽмº°ø·üÀ» ³ôÀÌ°í °Ç°­ÇÑ ÀÚ¼ÕÀ» È®º¸ÇÒ ¼ö ÀÖ°Ô µÇ¾ú½À´Ï´Ù. ¶ÇÇÑ ºÒÀÓ Ä¡·á¿¡ ´ëÇÑ ÀνÄÀÌ ³ô¾ÆÁö°í ³«ÀÎÀÌ »ç¶óÁö¸é¼­ ¼ö¿ä¸¦ ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ±×·¯³ª À±¸®Àû ¹®Á¦, ¾ö°ÝÇÑ ±ÔÁ¦ »óȲ, ³ôÀº ¿î¿µ ºñ¿ë, ÀáÀçÀûÀÎ »çȸÀû ³«ÀÎ ¹× ÇÁ¶óÀ̹ö½Ã¿¡ ´ëÇÑ ¿ì·Á·Î ÀÎÇØ ±âÁõÀÚ¿Í ¼öÇýÀÚ ¸ðµÎ ÁÖÀúÇϰí ÀÖ´Â ½ÇÁ¤ÀÔ´Ï´Ù. »õ·Î¿î ºñÁî´Ï½º ±âȸ´Â ÀÇ·á ÀÎÇÁ¶ó°¡ ±¸ÃàµÇ°í ÀÖ´Â °³¹ßµµ»ó±¹À¸·ÎÀÇ È®Àå, ¼ÒºñÀÚ ±³À° ¹× »ó´ãÀ» À§ÇÑ °ß°íÇÑ ¿Â¶óÀÎ Ç÷§Æû ±¸Ãà, AI ±â¹Ý ¸ÅĪ ½Ã½ºÅÛ, À¯ÀüÀÚ ÇÁ·ÎÆÄÀϸµ °­È­, º¸°ü ¼Ö·ç¼Ç °³¼± µîÀÇ Çõ½Å¿¡ ÃÊÁ¡À» ¸ÂÃß¾ú½À´Ï´Ù. µîÀÇ Çõ½Å¿¡ ÁýÁßÇÔÀ¸·Î½á Å« »ç¾÷ ¼ºÀåÀ» ±â´ëÇÒ ¼ö ÀÖ½À´Ï´Ù. À¯ÀüÀÚ Áúȯ ¹× °³ÀÎ ¸ÂÃãÇü ÀÇ·á¿¡ ´ëÇÑ ¿¬±¸¸¦ À§ÇØ ÇコÄÉ¾î ¹× »ý¸í°øÇÐ ±â¾÷°úÀÇ Çù·ÂÀº ±ÍÁßÇÑ ÅëÂû·Â°ú ÇØ°áÃ¥À» Á¦°øÇÒ ¼ö ÀÖ½À´Ï´Ù. °á±¹, Á¤ÀÚÀºÇà ½ÃÀåÀº ¿©ÀüÈ÷ Æ´»õ ½ÃÀåÀÌÀÚ °³¹ß ÁßÀÎ ºÐ¾ßÀ̸ç, À±¸®Àû, ±ÔÁ¦Àû º¹À⼺¿¡ °¡·Î¸·Çô ÀÖÁö¸¸, »çȸÀû ¼ö¿ë°ú ±â¼ú ¹ßÀü°ú ÇÔ²² È®Àå ¹× °³¼±ÀÇ ±âȸ¸¦ °¡Áö°í ÀÖ½À´Ï´Ù. À±¸®Àû °üÇà, ºñ¿ë °ü¸®, ±³À°¿¡ ÁßÁ¡À» µÎ´Â °ÍÀº ÀÌ ºÐ¾ß¿¡¼­ ¼º°øÇϰíÀÚ ÇÏ´Â ±â¾÷¿¡°Ô ¸Å¿ì Áß¿äÇÕ´Ï´Ù.

ÁÖ¿ä ½ÃÀå Åë°è
±âÁØ ¿¬µµ(2023) 47¾ï 2,000¸¸ ´Þ·¯
¿¹Ãø ¿¬µµ(2024³â) 49¾ï 3,000¸¸ ´Þ·¯
¿¹Ãø ¿¬µµ(2030³â) 63¾ï 8,000¸¸ ´Þ·¯
CAGR(%) 4.38%

½ÃÀå ¿ªÇÐ: ºü¸£°Ô ÁøÈ­ÇÏ´Â Á¤ÀÚÀºÇà ½ÃÀåÀÇ ÁÖ¿ä ½ÃÀå ÀλçÀÌÆ® °ø°³

Á¤ÀÚÀºÇà ½ÃÀåÀº ¼ö¿ä ¹× °ø±ÞÀÇ ¿ªµ¿ÀûÀÎ »óÈ£ÀÛ¿ëÀ» ÅëÇØ º¯È­Çϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ½ÃÀå ¿ªÇÐÀÇ ÁøÈ­¸¦ ÀÌÇØÇÔÀ¸·Î½á ±â¾÷Àº Á¤º¸¿¡ ÀÔ°¢ÇÑ ÅõÀÚ °áÁ¤À» ³»¸®°í, Àü·«Àû ÀÇ»ç°áÁ¤À» Á¤±³È­Çϸç, »õ·Î¿î ºñÁî´Ï½º ±âȸ¸¦ Æ÷ÂøÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Æ®·»µå¸¦ Á¾ÇÕÀûÀ¸·Î ÆÄ¾ÇÇÔÀ¸·Î½á ±â¾÷Àº Á¤Ä¡Àû, Áö¸®Àû, ±â¼úÀû, »çȸÀû, °æÁ¦Àû ¿µ¿ª Àü¹Ý¿¡ °ÉÄ£ ´Ù¾çÇÑ ¸®½ºÅ©¸¦ ÁÙÀÏ ¼ö ÀÖÀ¸¸ç, ¼ÒºñÀÚ Çൿ°ú ±×°ÍÀÌ Á¦Á¶ ºñ¿ë ¹× ±¸¸Å µ¿Çâ¿¡ ¹ÌÄ¡´Â ¿µÇâÀ» º¸´Ù ¸íÈ®ÇÏ°Ô ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù.

  • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
    • »ýȰ¾ç½ÄÀÇ º¯È­¿Í ³²³à ºÒÀÓÁõ Áõ°¡
    • °¡Ã³ºÐ¼Òµæ Áõ°¡¿Í Àΰø¼öÁ¤ ±â¼ú¿¡ ´ëÇÑ ÅõÀÚ È®´ë
    • ºÒÀÓ Ä¡·á °ü±¤¿¡ ´ëÇÑ Á¤ÀÚ ÀºÇà¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡
  • ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ
    • ³Ãµ¿ º¸Á¸ ¹× ±âŸ Á¤ÀÚ º¸Á¸ ±â¼ú¿¡ µå´Â ³ôÀº ºñ¿ë
  • ½ÃÀå ±âȸ
    • Á¤ÀÚ ÀúÀå ¹× Ã³¸® ´É·ÂÀÇ ±â¼úÀû Áøº¸
    • Á¤ÀÚ ±âÁõÀ» ÃËÁøÇÏ´Â À¯¸®ÇÑ Á¤ºÎ ±ÔÁ¦
  • ½ÃÀå °úÁ¦
    • Á¦°øµÈ Á¤ÀÚÀÇ Ç°Áú ¹× ¾ÈÀü¿¡ ´ëÇÑ ¿ì·Á

Portre's Five Forces: Á¤ÀÚÀºÇà ½ÃÀå Ž»öÀ» À§ÇÑ Àü·« µµ±¸

Portre's Five Forces ÇÁ·¹ÀÓ¿öÅ©´Â ½ÃÀå »óȲ°æÀï ±¸µµ¸¦ ÀÌÇØÇÏ´Â Áß¿äÇÑ µµ±¸ÀÔ´Ï´Ù. Portre's Five Forces ÇÁ·¹ÀÓ¿öÅ©´Â ±â¾÷ÀÇ °æÀï·ÂÀ» Æò°¡Çϰí Àü·«Àû ±âȸ¸¦ Ž»öÇÒ ¼ö ÀÖ´Â ¸íÈ®ÇÑ ¹æ¹ýÀ» Á¦°øÇÕ´Ï´Ù. ÀÌ ÇÁ·¹ÀÓ¿öÅ©´Â ±â¾÷ÀÌ ½ÃÀå ³» ¼¼·Âµµ¸¦ Æò°¡ÇÏ°í ½Å±Ô »ç¾÷ÀÇ ¼öÀͼºÀ» ÆÇ´ÜÇÏ´Â µ¥ µµ¿òÀÌ µË´Ï´Ù. ÀÌ·¯ÇÑ ÅëÂû·ÂÀ» ÅëÇØ ±â¾÷Àº °­Á¡À» Ȱ¿ëÇϰí, ¾àÁ¡À» ÇØ°áÇϰí, ÀáÀçÀûÀÎ µµÀüÀ» ÇÇÇϰí, º¸´Ù °­·ÂÇÑ ½ÃÀå Æ÷Áö¼Å´×À» È®º¸ÇÒ ¼ö ÀÖ½À´Ï´Ù.

PESTLE ºÐ¼® : Á¤ÀÚÀºÇà ½ÃÀå¿¡¼­ÀÇ ¿ÜºÎ ¿µÇâ ÆÄ¾Ç

¿ÜºÎ °Å½Ã ȯ°æ ¿äÀÎÀº Á¤ÀÚÀºÇà ½ÃÀåÀÇ ¼º°ú ¿ªÇÐÀ» Çü¼ºÇÏ´Â µ¥ ¸Å¿ì Áß¿äÇÑ ¿ªÇÒÀ» ÇÕ´Ï´Ù. Á¤Ä¡Àû, °æÁ¦Àû, »çȸÀû, ±â¼úÀû, ¹ýÀû, ȯ°æÀû ¿äÀο¡ ´ëÇÑ ºÐ¼®Àº ÀÌ·¯ÇÑ ¿µÇâÀ» Ž»öÇÏ´Â µ¥ ÇÊ¿äÇÑ Á¤º¸¸¦ Á¦°øÇϸç, PESTLE ¿äÀÎÀ» Á¶»çÇÔÀ¸·Î½á ±â¾÷Àº ÀáÀçÀû À§Çè°ú ±âȸ¸¦ ´õ Àß ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ºÐ¼®À» ÅëÇØ ±â¾÷Àº ±ÔÁ¦, ¼ÒºñÀÚ ¼±È£µµ, °æÁ¦ µ¿ÇâÀÇ º¯È­¸¦ ¿¹ÃøÇÏ°í ¼±Á¦ÀûÀÌ°í ´Éµ¿ÀûÀÎ ÀÇ»ç°áÁ¤À» ³»¸± Áغñ¸¦ ÇÒ ¼ö ÀÖ½À´Ï´Ù.

½ÃÀå Á¡À¯À² ºÐ¼® Á¤ÀÚÀºÇà ½ÃÀå¿¡¼­°æÀï ±¸µµ ÆÄ¾Ç

Á¤ÀÚ ÀºÇà ½ÃÀåÀÇ »ó¼¼ÇÑ ½ÃÀå Á¡À¯À² ºÐ¼®À» ÅëÇØ °ø±Þ¾÷üÀÇ ¼º°ú¸¦ Á¾ÇÕÀûÀ¸·Î Æò°¡ÇÒ ¼ö ÀÖ½À´Ï´Ù. ±â¾÷Àº ¼öÀÍ, °í°´ ±â¹Ý, ¼ºÀå·ü°ú °°Àº ÁÖ¿ä ÁöÇ¥¸¦ ºñ±³ÇÏ¿© °æÀïÀû À§Ä¡¸¦ ÆÄ¾ÇÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ ºÐ¼®Àº ½ÃÀåÀÇ ÁýÁßÈ­, ´ÜÆíÈ­, ÅëÇÕÀÇ Ãß¼¼¸¦ ÆÄ¾ÇÇÒ ¼ö ÀÖÀ¸¸ç, °ø±Þ¾÷ü´Â Ä¡¿­ÇÑ °æÀï ¼Ó¿¡¼­ ÀÚ½ÅÀÇ ÀÔÁö¸¦ °­È­ÇÒ ¼ö ÀÖ´Â Àü·«Àû ÀÇ»ç°áÁ¤À» ³»¸®´Â µ¥ ÇÊ¿äÇÑ ÅëÂû·ÂÀ» ¾òÀ» ¼ö ÀÖ½À´Ï´Ù.

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º Á¤ÀÚÀºÇà ½ÃÀå¿¡¼­ÀÇ º¥´õ ¼º°ú Æò°¡

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º´Â Á¤ÀÚÀºÇà ½ÃÀå¿¡¼­ °ø±Þ¾÷ü¸¦ Æò°¡ÇÏ´Â Áß¿äÇÑ µµ±¸ÀÔ´Ï´Ù. ÀÌ ¸ÅÆ®¸¯½º¸¦ ÅëÇØ ºñÁî´Ï½º Á¶Á÷Àº º¥´õÀÇ ºñÁî´Ï½º Àü·«°ú Á¦Ç° ¸¸Á·µµ¸¦ ±â¹ÝÀ¸·Î Æò°¡ÇÏ¿© ¸ñÇ¥¿¡ ºÎÇÕÇÏ´Â Á¤º¸¿¡ ÀÔ°¢ÇÑ ÀÇ»ç°áÁ¤À» ³»¸± ¼ö ÀÖÀ¸¸ç, 4°³ÀÇ »çºÐ¸éÀ¸·Î º¥´õ¸¦ ¸íÈ®Çϰí Á¤È®ÇÏ°Ô ¼¼ºÐÈ­ÇÏ¿© Àü·« ¸ñÇ¥¿¡ °¡Àå ÀûÇÕÇÑ ÆÄÆ®³Ê¿Í ¼Ö·ç¼ÇÀ» ½Äº°ÇÒ ¼ö ÀÖ½À´Ï´Ù. Àü·« ¸ñÇ¥¿¡ °¡Àå ÀûÇÕÇÑ ÆÄÆ®³Ê¿Í ¼Ö·ç¼ÇÀ» ½Äº°ÇÒ ¼ö ÀÖ½À´Ï´Ù.

Á¤ÀÚÀºÇà ½ÃÀå¿¡¼­ÀÇ ¼º°øÀ» À§ÇÑ Àü·« ºÐ¼® ¹× Ãßõ Á¤ÀÚÀºÇà ½ÃÀå¿¡¼­ÀÇ ¼º°ø °æ·Î¸¦ ±×¸³´Ï´Ù.

Á¤ÀÚÀºÇà ½ÃÀå Àü·« ºÐ¼®Àº ¼¼°è ½ÃÀå¿¡¼­ ÀÔÁö¸¦ °­È­ÇϰíÀÚ ÇÏ´Â ±â¾÷¿¡°Ô ÇʼöÀûÀÔ´Ï´Ù. ÁÖ¿ä ÀÚ¿ø, ¿ª·® ¹× ¼º°ú ÁöÇ¥¸¦ °ËÅäÇÔÀ¸·Î½á ±â¾÷Àº ¼ºÀå ±âȸ¸¦ ½Äº°ÇÏ°í °³¼±ÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Á¢±Ù ¹æ½ÄÀ» ÅëÇØ °æÀï ȯ°æÀÇ µµÀüÀ» ±Øº¹ÇÏ°í »õ·Î¿î ºñÁî´Ï½º ±âȸ¸¦ Ȱ¿ëÇÏ¿© Àå±âÀûÀÎ ¼º°øÀ» °ÅµÑ ¼ö ÀÖµµ·Ï ÁغñÇÒ ¼ö ÀÖ½À´Ï´Ù.

ÀÌ º¸°í¼­´Â ÁÖ¿ä °ü½É ºÐ¾ß¸¦ Æ÷°ýÇÏ´Â ½ÃÀå¿¡ ´ëÇÑ Á¾ÇÕÀûÀÎ ºÐ¼®À» Á¦°øÇÕ´Ï´Ù.

1. ½ÃÀå ħÅõµµ : ÇöÀç ½ÃÀå ȯ°æÀÇ »ó¼¼ÇÑ °ËÅä, ÁÖ¿ä ±â¾÷ÀÇ ±¤¹üÀ§ÇÑ µ¥ÀÌÅÍ, ½ÃÀå µµ´Þ ¹üÀ§ ¹× Àü¹ÝÀûÀÎ ¿µÇâ·Â Æò°¡.

2. ½ÃÀå °³Ã´µµ: ½ÅÈï ½ÃÀå¿¡¼­ÀÇ ¼ºÀå ±âȸ¸¦ ÆÄ¾ÇÇϰí, ±âÁ¸ ºÐ¾ßÀÇ È®Àå °¡´É¼ºÀ» Æò°¡Çϸç, ¹Ì·¡ ¼ºÀåÀ» À§ÇÑ Àü·«Àû ·Îµå¸ÊÀ» Á¦°øÇÕ´Ï´Ù.

3. ½ÃÀå ´Ù°¢È­ : ÃÖ±Ù Á¦Ç° Ãâ½Ã, ¹Ì°³Ã´ Áö¿ª, ¾÷°èÀÇ ÁÖ¿ä ¹ßÀü, ½ÃÀåÀ» Çü¼ºÇÏ´Â Àü·«Àû ÅõÀÚ¸¦ ºÐ¼®ÇÕ´Ï´Ù.

4. °æÀï Æò°¡ ¹× Á¤º¸ : °æÀï ±¸µµ¸¦ öÀúÈ÷ ºÐ¼®ÇÏ¿© ½ÃÀå Á¡À¯À², »ç¾÷ Àü·«, Á¦Ç° Æ÷Æ®Æú¸®¿À, ÀÎÁõ, ±ÔÁ¦ ´ç±¹ÀÇ ½ÂÀÎ, ƯÇã µ¿Çâ, ÁÖ¿ä ±â¾÷ÀÇ ±â¼ú ¹ßÀü µîÀ» °ËÅäÇÕ´Ï´Ù.

5. Á¦Ç° °³¹ß ¹× Çõ½Å : ¹Ì·¡ ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÒ °ÍÀ¸·Î ¿¹»óµÇ´Â ÷´Ü ±â¼ú, ¿¬±¸ °³¹ß Ȱµ¿ ¹× Á¦Ç° Çõ½ÅÀ» °­Á¶ÇÕ´Ï´Ù.

ÀÌÇØ°ü°èÀÚµéÀÌ ÃæºÐÇÑ Á¤º¸¸¦ ¹ÙÅÁÀ¸·Î ÀÇ»ç°áÁ¤À» ³»¸± ¼ö ÀÖµµ·Ï ´ÙÀ½°ú °°Àº Áß¿äÇÑ Áú¹®¿¡ ´ëÇÑ ´äº¯µµ Á¦°øÇÕ´Ï´Ù.

1. ÇöÀç ½ÃÀå ±Ô¸ð¿Í ÇâÈÄ ¼ºÀå Àü¸ÁÀº?

2. ÃÖ°íÀÇ ÅõÀÚ ±âȸ¸¦ Á¦°øÇÏ´Â Á¦Ç°, ºÎ¹®, Áö¿ªÀº?

3. ½ÃÀåÀ» Çü¼ºÇÏ´Â ÁÖ¿ä ±â¼ú µ¿Çâ°ú ±ÔÁ¦ÀÇ ¿µÇâÀº?

4. ÁÖ¿ä º¥´õÀÇ ½ÃÀå Á¡À¯À²°ú °æÀï Æ÷Áö¼ÇÀº?

5.º¥´õ ½ÃÀå ÁøÀÔ ¹× ö¼ö Àü·«ÀÇ ¿øµ¿·ÂÀÌ µÇ´Â ¼öÀÍ¿ø°ú Àü·«Àû ±âȸ´Â ¹«¾ùÀΰ¡?

¸ñÂ÷

Á¦1Àå ¼­¹®

Á¦2Àå Á¶»ç ¹æ¹ý

Á¦3Àå ÁÖ¿ä ¿ä¾à

Á¦4Àå ½ÃÀå °³¿ä

Á¦5Àå ½ÃÀå ÀλçÀÌÆ®

  • ½ÃÀå ¿ªÇÐ
    • ¼ºÀå ÃËÁø¿äÀÎ
    • ¼ºÀå ¾ïÁ¦¿äÀÎ
    • ±âȸ
    • °úÁ¦
  • ½ÃÀå ¼¼ºÐÈ­ ºÐ¼®
  • PorterÀÇ Five Forces ºÐ¼®
  • PESTLE ºÐ¼®
    • Á¤Ä¡
    • °æÁ¦
    • »çȸ
    • ±â¼ú
    • ¹ý·ü
    • ȯ°æ

Á¦6Àå Á¤ÀÚÀºÇà ½ÃÀå : ±âºÎÀÚ À¯Çüº°

  • ÀÍ¸í ±âºÎÀÚ
  • ±âÁ¸ ±âÁõÀÚ

Á¦7Àå Á¤ÀÚÀºÇà ½ÃÀå : ¼­ºñ½º À¯Çüº°

  • À¯Àü »ó´ã
  • Á¤¾× °Ë»ç
  • Á¤ÀÚ º¸Á¸

Á¦8Àå Á¤ÀÚÀºÇà ½ÃÀå : ¿ëµµº°

  • ü¿Ü¼öÁ¤(IVF)
  • Àڱðæ°ü³» ¼öÁ¤(ICI)
  • Àڱó» Àΰø¼öÁ¤(IUI)

Á¦9Àå Á¤ÀÚÀºÇà ½ÃÀå : ÃÖÁ¾ ¿ëµµº°

  • ±âÁõÀÚ¿¡ ÀÇÇÑ Àΰø¼öÁ¤
  • ü¿Ü¼öÁ¤

Á¦10Àå ¾Æ¸Þ¸®Ä«ÀÇ Á¤ÀÚÀºÇà ½ÃÀå

  • ¾Æ¸£ÇîÆ¼³ª
  • ºê¶óÁú
  • ij³ª´Ù
  • ¸ß½ÃÄÚ
  • ¹Ì±¹

Á¦11Àå ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ Á¤ÀÚÀºÇà ½ÃÀå

  • È£ÁÖ
  • Áß±¹
  • Àεµ
  • Àεµ³×½Ã¾Æ
  • ÀϺ»
  • ¸»·¹À̽þÆ
  • Çʸ®ÇÉ
  • ½Ì°¡Æ÷¸£
  • Çѱ¹
  • ´ë¸¸
  • ű¹
  • º£Æ®³²

Á¦12Àå À¯·´, Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ Á¤ÀÚÀºÇà ½ÃÀå

  • µ§¸¶Å©
  • ÀÌÁýÆ®
  • Çɶõµå
  • ÇÁ¶û½º
  • µ¶ÀÏ
  • À̽º¶ó¿¤
  • ÀÌÅ»¸®¾Æ
  • ³×´ú¶õµå
  • ³ªÀÌÁö¸®¾Æ
  • ³ë¸£¿þÀÌ
  • Æú¶õµå
  • īŸ¸£
  • ·¯½Ã¾Æ
  • »ç¿ìµð¾Æ¶óºñ¾Æ
  • ³²¾ÆÇÁ¸®Ä«°øÈ­±¹
  • ½ºÆäÀÎ
  • ½º¿þµ§
  • ½ºÀ§½º
  • ÅÍŰ
  • ¾Æ¶ø¿¡¹Ì¸®Æ®(UAE)
  • ¿µ±¹

Á¦13Àå °æÀï ±¸µµ

  • ½ÃÀå Á¡À¯À² ºÐ¼®, 2023
  • FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º, 2023
  • °æÀï ½Ã³ª¸®¿À ºÐ¼®
  • Àü·« ºÐ¼®°ú Á¦¾È

±â¾÷ ¸®½ºÆ®

  • Androcryos
  • California Cryobank by CooperSurgical
  • CFC Global Pty Ltd(Addam Donor Bank)
  • Cordlife Sciences India Pvt. Ltd.
  • CryoChoice
  • Cryogenic Laboratories, Inc.
  • Cryos International ApS
  • European Sperm Bank ApS
  • FairFax Cryobank
  • Genetics & IVF Institute
  • Indian Spermtech
  • Lifecell International Pvt. Ltd.
  • London Sperm Bank
  • New England Cryogenic Center, Inc.
  • Pride Angel Ltd
  • ReproTech LLC
  • Seattle Sperm Bank
  • Sperm Bank Inc.
  • TFP Sperm Bank Germany GmbH
  • The Sperm Bank of California
  • Xytex Corporation
LSH

The Sperm Banks Market was valued at USD 4.72 billion in 2023, expected to reach USD 4.93 billion in 2024, and is projected to grow at a CAGR of 4.38%, to USD 6.38 billion by 2030.

The sperm bank market is a specialized sector within the broader fertility services industry, focusing on the collection, storage, and provision of sperm for artificial insemination and other fertility treatments. It caters to a diverse clientele, including couples experiencing infertility, single women, and same-sex couples seeking to conceive. The necessity of sperm banks arises from increasing infertility rates, driven by lifestyle changes, medical conditions, delayed parenthood, and rising acceptance of single and LGBTQ+ parent families. Their applications extend to assisted reproductive technologies (ART) like in vitro fertilization (IVF), with significant demand expected in regions with advanced healthcare systems and progressive legal norms supporting fertility services. End-user segments primarily include fertility clinics, hospitals, and research institutions. Market growth is influenced by technological advancements in cryopreservation, genetic testing, and screening for donor selection, ensuring higher pregnancy success rates and healthier offspring. Increasing awareness and destigmatization of fertility treatments also propel demand. However, challenges such as ethical concerns, stringent regulatory landscapes, and high operational costs pose barriers, while potential social stigmas and privacy concerns can deter both donors and recipients. Emerging opportunities lie in expanding toward developing regions with improving healthcare infrastructures and creating robust online platforms for consumer education and consultation. Focused innovation in AI-driven matching systems, enhanced genetic profiling, and improved storage solutions promises significant business growth. Collaborations with healthcare and biotech firms for research on genetic disorders and personalized medicine may yield valuable insights and solutions. Ultimately, the sperm banking market remains a niche yet evolving field, with opportunities for expansion and improvement alongside societal acceptance and technological progression, albeit hindered by ethical and regulatory complexities. Emphasizing ethical practices, cost management, and education will be crucial for businesses aiming to thrive in this domain.

KEY MARKET STATISTICS
Base Year [2023] USD 4.72 billion
Estimated Year [2024] USD 4.93 billion
Forecast Year [2030] USD 6.38 billion
CAGR (%) 4.38%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Sperm Banks Market

The Sperm Banks Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Changing lifestyle patterns and increasing incidence of male and female infertility
    • Rising disposable income and growing investment in artificial insemination techniques
    • Growing demand of sperm banks for fertility tourism
  • Market Restraints
    • High cost of cryopreservation and other techniques for storage of sperms
  • Market Opportunities
    • Technological advancements in the sperm storage and processing capacities
    • Favorable government regulations promoting sperm donation
  • Market Challenges
    • Concerns associated with the quality and safety of donated sperms

Porter's Five Forces: A Strategic Tool for Navigating the Sperm Banks Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Sperm Banks Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Sperm Banks Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Sperm Banks Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Sperm Banks Market

A detailed market share analysis in the Sperm Banks Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Sperm Banks Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Sperm Banks Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Sperm Banks Market

A strategic analysis of the Sperm Banks Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Sperm Banks Market, highlighting leading vendors and their innovative profiles. These include Androcryos, California Cryobank by CooperSurgical, CFC Global Pty Ltd (Addam Donor Bank), Cordlife Sciences India Pvt. Ltd., CryoChoice, Cryogenic Laboratories, Inc., Cryos International ApS, European Sperm Bank ApS, FairFax Cryobank, Genetics & IVF Institute, Indian Spermtech, Lifecell International Pvt. Ltd., London Sperm Bank, New England Cryogenic Center, Inc., Pride Angel Ltd, ReproTech LLC, Seattle Sperm Bank, Sperm Bank Inc., TFP Sperm Bank Germany GmbH, The Sperm Bank of California, and Xytex Corporation.

Market Segmentation & Coverage

This research report categorizes the Sperm Banks Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Donor Type, market is studied across Anonymous Donor and Known Donor.
  • Based on Service Type, market is studied across Genetic Consultation, Semen Analysis, and Sperm Storage.
  • Based on Application, market is studied across In-Vitro Fertilization (IVF)), Intracervical Insemination (ICI), and Intrauterine Insemination (IUI).
  • Based on End Use, market is studied across Donor Insemination and In Vitro Fertilization.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Changing lifestyle patterns and increasing incidence of male and female infertility
      • 5.1.1.2. Rising disposable income and growing investment in artificial insemination techniques
      • 5.1.1.3. Growing demand of sperm banks for fertility tourism
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of cryopreservation and other techniques for storage of sperms
    • 5.1.3. Opportunities
      • 5.1.3.1. Technological advancements in the sperm storage and processing capacities
      • 5.1.3.2. Favorable government regulations promoting sperm donation
    • 5.1.4. Challenges
      • 5.1.4.1. Concerns associated with the quality and safety of donated sperms
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Sperm Banks Market, by Donor Type

  • 6.1. Introduction
  • 6.2. Anonymous Donor
  • 6.3. Known Donor

7. Sperm Banks Market, by Service Type

  • 7.1. Introduction
  • 7.2. Genetic Consultation
  • 7.3. Semen Analysis
  • 7.4. Sperm Storage

8. Sperm Banks Market, by Application

  • 8.1. Introduction
  • 8.2. In-Vitro Fertilization (IVF))
  • 8.3. Intracervical Insemination (ICI)
  • 8.4. Intrauterine Insemination (IUI)

9. Sperm Banks Market, by End Use

  • 9.1. Introduction
  • 9.2. Donor Insemination
  • 9.3. In Vitro Fertilization

10. Americas Sperm Banks Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Sperm Banks Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Sperm Banks Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Androcryos
  • 2. California Cryobank by CooperSurgical
  • 3. CFC Global Pty Ltd (Addam Donor Bank)
  • 4. Cordlife Sciences India Pvt. Ltd.
  • 5. CryoChoice
  • 6. Cryogenic Laboratories, Inc.
  • 7. Cryos International ApS
  • 8. European Sperm Bank ApS
  • 9. FairFax Cryobank
  • 10. Genetics & IVF Institute
  • 11. Indian Spermtech
  • 12. Lifecell International Pvt. Ltd.
  • 13. London Sperm Bank
  • 14. New England Cryogenic Center, Inc.
  • 15. Pride Angel Ltd
  • 16. ReproTech LLC
  • 17. Seattle Sperm Bank
  • 18. Sperm Bank Inc.
  • 19. TFP Sperm Bank Germany GmbH
  • 20. The Sperm Bank of California
  • 21. Xytex Corporation
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦